Literature DB >> 17607547

Selective activation of mast cells in rheumatoid synovial tissue results in production of TNF-alpha, IL-1beta and IL-1Ra.

C Sandler1, K A Lindstedt, S Joutsiniemi, J Lappalainen, T Juutilainen, J Kolah, P T Kovanen, K K Eklund.   

Abstract

OBJECTIVES AND
DESIGN: To study the consequences of mast cell activation in human synovial tissue.
METHODS: Synovial tissue was obtained from 18 RA patients and mast cells was selectively activated in synovial tissue explant cultures. Expression of TNF-alpha, IL-1beta and IL-1Ra were determined and tissue distribution of IL-1beta was studied.
RESULTS: Compared to untreated synovia, selective activation of synovial mast cells increased significantly the production of TNF-alpha (0.49 +/- 0.88 vs. 4.56 +/- 3.18 pg/mg wet tissue, p < 0.001) and IL-1beta (0.058 +/- 0.032 vs. 2.55 +/- 1.98 pg/mg wet tissue, p = 0.013). The expression of TNF-alpha and IL-1beta mRNA increased significantly (19-fold (p = 0.009) and 13-fold (p = 0.031), respectively). Mast cell activation induced IL-1beta expression in particular in nearby CD68 positive synovial macrophages. Secretion of IL-1Ra was also increased but to a lesser degree than that of IL-1beta.
CONCLUSIONS: Synovial mast cells produce proinflammmatory cytokines and may thus contribute to the inflammation in RA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17607547     DOI: 10.1007/s00011-007-6135-1

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  18 in total

Review 1.  Immune mediators of chronic pelvic pain syndrome.

Authors:  Stephen F Murphy; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Nat Rev Urol       Date:  2014-04-01       Impact factor: 14.432

Review 2.  New insights into the role of mast cells in autoimmunity: evidence for a common mechanism of action?

Authors:  Margaret E Walker; Julianne K Hatfield; Melissa A Brown
Journal:  Biochim Biophys Acta       Date:  2011-02-25

Review 3.  Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases.

Authors:  Jia-Ming Xu; Guo-Ping Shi
Journal:  Endocr Rev       Date:  2012-01-12       Impact factor: 19.871

4.  Suppression of antibody-mediated arthritis in mice by Fab fragments of the mediating antibodies.

Authors:  S Yoshino; M Sasahara; Pilaiwanwadee Hutamekalin; K Yamaki; N Mizutani; H Kuramoto
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

5.  Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33.

Authors:  Geethani Bandara; Michael A Beaven; Ana Olivera; Alasdair M Gilfillan; Dean D Metcalfe
Journal:  Eur J Immunol       Date:  2015-09-09       Impact factor: 5.532

6.  A crucial role for TNF-alpha in mediating neutrophil influx induced by endogenously generated or exogenous chemokines, KC/CXCL1 and LIX/CXCL5.

Authors:  S M Vieira; H P Lemos; R Grespan; M H Napimoga; D Dal-Secco; A Freitas; T M Cunha; W A Verri; D A Souza-Junior; M C Jamur; K S Fernandes; C Oliver; J S Silva; M M Teixeira; F Q Cunha
Journal:  Br J Pharmacol       Date:  2009-08-20       Impact factor: 8.739

7.  TNF Production in Activated RBL-2H3 Cells Requires Munc13-4.

Authors:  Tolulope E Ayo; Pratikshya Adhikari; Shuzo Sugita; Hao Xu
Journal:  Inflammation       Date:  2020-04       Impact factor: 4.092

Review 8.  Diverse exocytic pathways for mast cell mediators.

Authors:  Hao Xu; Na-Ryum Bin; Shuzo Sugita
Journal:  Biochem Soc Trans       Date:  2018-02-22       Impact factor: 5.407

9.  IL-17A expression is localised to both mononuclear and polymorphonuclear synovial cell infiltrates.

Authors:  Ellen M Moran; René Heydrich; Chin Teck Ng; Tajvur P Saber; Jennifer McCormick; Joachim Sieper; Heiner Appel; Ursula Fearon; Douglas J Veale
Journal:  PLoS One       Date:  2011-08-24       Impact factor: 3.240

10.  A proof-of-concept study with the tyrosine kinase inhibitor nilotinib in spondyloarthritis.

Authors:  Jacqueline E Paramarta; Maureen C Turina; Troy Noordenbos; Tanja F Heijda; Iris C Blijdorp; Nataliya Yeremenko; Dominique Baeten
Journal:  J Transl Med       Date:  2016-10-27       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.